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Background: Clinical assessment and prognostic stratiﬁcation of primary varicose veins have remained controversial
and themolecular pathogenesis is unknown. Previous datahave suggested a contributionof theMTHFR (methylene-
tetrahydrofolate reductase) polymorphism c.677CNT.
Methods:We collected blood and vein specimens from 159 consecutive patients undergoing varicose vein surgery,
or autologous vein reconstruction for arterial occlusive disease as controls. We compared the frequencies of
c.677CNT and another polymorphism ofMTHFR, c.1298ANC, with morphology and types of complicated disease.
Morphology was recorded as a trunk or perforator type and peripheral congestive complication was deﬁned as
chronic venous insufﬁciency (CEAP C3–6) associated with edema and skin manifestations.
Findings:Multivariate analysis of genotypes for c.677CNT and c.1298ANC indicated that c.677CNTwas associated sig-
niﬁcantly with the trunk phenotype (43/53 patients, 81%, p b 0.01), while c.1298ANC was associated signiﬁcantly
with the perforator phenotype (18/24 patients, 75%, p b 0.01) of primary varicose veins. Accordingly, when both
c.677CNT and c.1298ANC displayed a heterozygous genotype, the patients were more likely to present with both
phenotypes. Additionally, c.1298ANC was found to be strongly linked to the congestive complication
(34/51 patients, 67%, p b 0.01).
Interpretation: Both polymorphisms of MTHFRmay be involved in the morphological speciﬁcation of primary
varicose veins and contribute to the development of complicated disease.
Funding: None.© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Primary varicose vein disease constitutes one of the most frequent
inherited disorders worldwide and entails a broad spectrum of cos-
metic, psychological, medical, and socio-economic implications (Evans
et al., 1994; Carpentier et al., 2004). Family based investigations sug-
gested an autosomal dominant inheritance (Cornu-Thenard et al.,
1994; Hach, 1967), but the origin of variant clinical courses and mor-
phological presentations is still unknown. This has resulted in a long
lasting and sometimes confusing debate on how to deal and treat best
(Pannier and Rabe, 2012; Gloviczki and Gloviczki, 2012).
Trunk and perforator types (Fig. 1a and b) of complicated and uncom-
plicated disease suggest different subsets of genetic origin. ThromboticStädtisches Klinikum Solingen,
Wilmanns).
. This is an open access article underdisease has been closely related to a common homozygousmutant geno-
type (TT) at c.677CNT, the most studied polymorphism of the MTHFR
(methylenetetrahydrofolate reductase) gene (Milio et al., 2008;
Wilmanns et al., 2011), coding for a key enzyme of one-carbonmetab-
olism. The prevalence of c.677CNT accurately overlaps with geographic
variations in the incidence of primary varicose veins (Wilmanns et al.,
2011;Wilcken et al., 2003; Raffetto, 2011) and has been previously linked
to the occurrence of varicose veins (Sverdlova et al., 1998).
Primary varicose veins result from an asymmetric remodeling of ex-
tracellular matrix and smooth muscle cells (Lim and Davies, 2009;
Naoum and Hunter, 2007; Somers and Knaapen, 2006) contributing to
wall thickening, valve incompetence and their typical corkscrew appear-
ance. Pathognomonic tortuosities provide undistinguishable features of
palpation and inspection and thus support genetic considerations.
In this study, we report an association between the c.677CNT and the
second most studied polymorphism of theMTHFR gene, c.1298ANC, both
of which are linked to reduced enzyme activity, with morphologicalthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
A         B
Fig. 1. Two different types of valvular incompetence occur in primary varicose veins
associated with two different types of clinical presentation. A, trunk type axial incompe-
tence, begins at the junctional valve and progressively advances towards the medial
malleolus in case of the greater or lateral malleolus in case of the smaller saphenous
vein. B, perforator type incompetence at one or more typical locations is frequently asso-
ciated with segmental axial incompetence of draining superfascial tributaries or trunk
veins.
159C. Wilmanns et al. / EBioMedicine 2 (2015) 158–164phenotypes and varying clinical presentations of primary varicose veins.
The heterozygous or homozygous c.677CNT genotype was associat-
ed with the trunk phenotype and the heterozygous or homozygous
c.1298ANC genotype with the perforator phenotype. We further
linked the double heterozygous c.677CNT/c.1298ANC genotype
(CTAC) with the combined trunk and perforator phenotype of primary
varicose veins. In addition, we associated the homozygous mutant CC
genotype at MTHFR c.1298ANC with the occurrence of congestive
disease. Thus, we provide a clue to the impact ofMTHFR polymorphisms
c.677CNT and c.1298ANC as hereditary components of primary varicose
vein disease.
2. Patients and Methods
Blood and vein tissue specimens were collected from 159 consecutive
surgical patients, including 116 with primary varicose veins and 37 con-
trols with arterial occlusive disease, at the Maria-Hilf-Krankenhaus in
54550Daun,Germany, and at the Johanniter-Krankenhaus in47228Duis-
burg, Germany, during a time period fromApril 2011 to August 2013. Ve-
nous tissue was obtained from removed and otherwise discharged
varicose veins or left-over fromvenous reconstruction of arterial occlusive
disease. The study was approved by the Ethic Committees of the Medical
Associations of Rhineland-Palatinate [No. 837.302.11 (7844)] and North
Rhine (No. 2012083), and all probands gave written and informed con-
sent to participate in the study in accordance with the declaration of
Helsinki's latest version. Probands with arterial occlusive disease and au-
tologous vein reconstruction served as controls.
Clinical and duplex examination assessed tortuosities, reﬂux, ve-
nous dilation, thrombosis, swelling, pigmentation, eczema, scar and
ulcer, inﬂammation, and painful, cord-like lesions to determine the
morphological phenotype or the occurrence of complicated, pro-
gressive disease (Suppl. Table 1). Morphology was recorded as the
trunk (Fig. 1a), perforator (Fig. 1b, Suppl. Table 2), or combined, in-
dicating the origin of reﬂux from the deep venous system, or uncertainphenotypes. Incompetent perforators were recorded in upright sitting
or standing position as dilated and draining into epifascial tributaries or
segments of incompetent trunk veins. Clinical symptoms resulting from
venous hypertension and mal-circulation were summarized as “conges-
tive complication”, “congestive disease”, or C3–6 according to the revised
CEAP (Clinical–Etiology–Anatomy–Pathophysiology) classiﬁcation for
chronic venous disorders (Suppl. Table 3) (Eklöf et al., 2004), and thus
distinguished from asymptomatic presentation, CEAP C2. Patients were
attributed to varicothrombosis in case of clinically apparent thrombotic
lesions of varicose veins or to recurrent disease in case of new lesions sub-
sequent to previous surgery in accordance with the REVAS deﬁnition
(Perrin et al., 2000).
Trunk type origin was from the greater saphenous vein in 67 of 116
patients (58%), from the smaller saphenous vein in 7 (6%), and from
both in two (2%). Perforator type origin was from the calf in 36 (31%),
the thigh in 6 (5%), and from both in 5 (4%). In 16 patients (14%) the
phenotype origin from one or the other or bothmorphologies remained
unclear (Suppl. Table 4). Six patients were excluded due to diagnostic
overlaps or secondary etiology (Suppl. Table 5). Exploratory pairwise
associations (via Chi-squared or Fisher's exact test, as appropriate) be-
tween the combined genotypes and the morphologies and complica-
tions were recorded (Tables 1 and 2, Suppl. Fig. 1).
Four patients (3%) were assessed as perforator type morphology
despite the occurrence of axial trunk incompetence due to proximal
perforator location (Suppl. Table 6). In some patients with congestive
(CEAP C3–6) or thrombotic disease or particularly in those with thigh
perforator incompetence, however, duplex examination was unable to
sufﬁciently discriminate between recirculation pathways of trunk or
perforator type origin. 16 patients, therefore, were classiﬁed as unclear
phenotypes (Tables 1 and 2, Suppl. Table 4). Six patients were excluded
from evaluation, ﬁve for primary varices in case of controls, and one for
systemic thrombophlebitis without evidence of primary varicose veins
(Table 2, Suppl. Table 5).
Blood specimens were collected from all patients during sampling
for routine examination. Vein tissue specimens were obtained from all
patients during surgery by dissecting an appropriate piece of tissue (at
least 1 cm2) fromaffected or unaffected (controls) veins and transferred
into a freezing vial. Blood and vein tissue specimenswere kept on ice for
a maximum of 6 h until storage at−80 °C. DNA extraction from frozen
blood samples was performed using the Puregene Kit (Qiagen, Hilden,
Germany). For DNA extraction from vein tissue specimens, a standard
salting out procedure was used. Genotyping for the MTHFR c.677CNT
and c.1298ANC polymorphisms was carried out from blood samples of
all patients using polymerase chain reaction (PCR) followed by pyrose-
quencing on a Pyromark Q96 ID Instrument (Qiagen). Primer sequences
and PCR conditions are available on request. Of 37 patients that
displayed heterozygous genotypes at MTHFR c.677CNT and/or MTHFR
c.1298ANC, parallel tests of blood and tissue specimenswere performed
and identical genotypes were obtained.
2.1. Statistical Methods
To test the association between two categorical variables, a Chi-
squared test, or Fisher's exact test was performed as appropriate. To
test the association between three or more categorical variables, a log-
linear analysis assuming a multinomial distribution was performed.
Forward stepwise variable selection was used to determine the ﬁnal
ﬁtted model where the initial model contained all main effects. The ap-
propriateness of the ﬁnal model was assessed via the deviance. Two
models – speciﬁcally the deviances of the ﬁnal ﬁtted model and the
ﬁtted model with the individual term of interest removed –were com-
pared to test the signiﬁcance of individual terms in the log-linearmodel.
Forward selectionwas preferred over backward selection due to sample
size limitations. A p-value less than 0.05 indicated that the individual
term signiﬁcantly contributed to the ﬁnal ﬁtted model. All statistical
analysis was performed in R (v. 3.1.1).
Table 1
Study group characteristics.
Age (mean ± SD) [years]
Controls Varicose veins
68.7 ± 9.7 60.9 ± 14.5
Sexa m 26 44
f 11 72
Morphology (n = 116)
Trunk type – 53
Perforator type – 24
Trunk and perforator type – 23
Trunk type or trunk and perforator type gsv – 67
ssv – 7
gsv + ssv – 2
Perforator type or trunk and perforator type Thigh – 36
Calf – 6
Thigh and calf – 5
Unclear – 16
Uncomplicated diseases CEAP C2 – 34
Complicated
disease
(n = 82)
Congestive diseaseb (n = 51) CEAP C3 – 24
CEAP C4 – 12
CEAP C5 – 1
CEAP C6 – 14
Recurrencesb (n = 21) Junctional type – 5
Perforator type – 11
Junctional and perforator type – 3
Residual veins – 2
Varicothrombosisb – 31
a Number of patients.
b Every primary varicose vein patient belongs to one type of morphology, however some are mentioned more than once in case of complicated disease phenotypes.; m, male; f, female;
gsv, greater saphenous vein; ssv, smaller saphenous vein.
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There was no association between c.677CNT genotype and
control/patient status as well as c.1298ANC and control/patient sta-
tus (c.677CNT: Fisher's exact test, p = 0.29; c.1298ANC: Fisher's
exact test, p = 1). Thus, we only considered those patients who
have the condition in the subsequent analysis.
A log-linear analysis, using a log-linear regression model with step-
wise selection at a level of 0.05, indicates that heterozygosity or homo-
zygosity for c.677CNT was signiﬁcantly associated with the trunk
phenotype (43/53 patients, 81%, p b 0.01) and heterozygosity or homo-
zygosity for c.1298ANC was signiﬁcantly associated with the perforator
phenotype (18/24 patients, 75%, p b 0.01). Furthermore, as by Fisher´s
exact test, double heterozygosity for c.677CNT and c.1298ANC was sig-
niﬁcantly associated with the combined trunk and perforator pheno-
type (18/23 patients, 78%, p b 0.01) (Table 2, Fig. 2a). There was also a
weak interaction between c.1298ANC and the trunk phenotype, howev-
er this did not reach signiﬁcance (p = 0.051).Table 2
Combined genotypes ofMTHFR c.677CNT and c.1298ANC and number of patients with different
or Fisher's exact test of association between indicated phenotype and combined genotype.
CCAA CTAA
Morphology Trunk type 8 20
Perforator type 2 3
Trunk and perforator type 1 1
Unclear 3 1
Complication Morphology recorded 14 25
Uncomplicated disease 7 9
Complicated disease 7 16
Varicothrombosisa 5 8
CEAP C3–6a 3 6
Recurrencesa – 5
Complication recorded 14 25
Controls 3 13
Excluded 1 1
Total participants 18 39
a Every primary varicose vein patient belongs to one type ofmorphology (n=116), however s
the minor allelic frequencies were 40% in patients and 35% in controls, for c.1298ANC 29% in patieA subsequent log-linear analysis including genotype and the unclear
phenotype indicates that the unclear phenotype was signiﬁcantly as-
sociated with a homozygous wild type (CC) genotype at c.677CNT (p b
0.01). The unclear phenotype was the highest for the homozygous
wild type genotype (CC) regardless of the c.1298ANC genotype, de-
creased for the heterozygous genotype (CT) and was not present for
the homozygous mutant genotype (TT) (Fig. 2b).
Log-linear analysis between genotype and complications indicates
that only c.1298ANC was signiﬁcantly associated with congestive
disease (CEAP C3–6, Fig. 2c, Suppl. Tables 3 and 7, p b 0.01). No other
signiﬁcant associations between genotype and complications were
recorded although visual inspection suggests a general relationship be-
tween mutant genotypes at both polymorphisms and complicated dis-
ease and in particular with recurrent disease (Fig. 2d, Suppl. Figs. 2–4).
Notably, more patients with junctional type recurrence, mimicking
trunk type morphology, presented with c.677CNT mutant genotype
compared to those with perforator type recurrence predominantly pre-
senting with mutant c.1298ANC (Suppl. Table 8). A further interactioncourses andmorphologies in varicose vein disease. p-Values are the result of a Chi-squared
CTAC TTAA CCAC CCCC n p-Val
5 18 2 – 53 b0.01
2 1 8 8 24 b0.01
18 2 1 – 23 b0.01
– – 8 4 16 b0.01
25 21 19 12 116
8 4 5 1 34 0.22
17 17 14 11 82
7 6 3 2 31 0.75
12 8 11 11 51 b0.01
3 5 4 4 21 0.24
25 21 19 12 116
7 3 8 3 37 0.46
– 2 1 1 6 –
32 26 28 16 159
ome arementionedmore than once in case of complicated disease phenotypes. For c.677CNT,
nts and 28% in controls.
Fig. 2. a) Association betweenmorphological phenotypes and combined genotypes. The proportion of each combined genotype with either trunk phenotype (red), perforator phenotype
(blue) or both (purple). Trunk phenotype increases from CC to TT genotypes at c. 677CNT, while perforator phenotype increases from AA to CC genotypes at c.1298ANC. The weak asso-
ciation between homozygous wildtype (AA) genotype at c.1298ANC and trunk phenotype can be seen in the combined genotype CCAA. We would expect to see more subjects with both
phenotypes, however, there are fewer subjects with the perforator phenotype, andmorewith the trunk phenotype thanwewould expect. Similarly, for the TTAA genotype there aremore
incidences of both phenotypes thanwewould expect.When both genotypes are heterozygous, the patient ismore likely to presentwith both phenotypes. b) Association between unclear
phenotypes and combined genotypes. The proportion of each combined genotype with either trunk phenotype (red), perforator phenotype (blue), combined (both) phenotype (purple)
or an unclear phenotype (ivory). The unclear phenotype is associated with a homozygous wildtype genotype (CC) at c.677CNT. c) Association between CEAP C3–6 complication and
combined genotype. Only the homozygous mutant genotype (CC) at c.1298ANC is signiﬁcantly associated with CEAP C3–6. The risk of a CEAP C3–6 complication increases from AA to
CC genotype at c.1298ANC. This would additionally suggest that the perforator phenotype is associated with CEAP C3–6. d) Association of CEAP C3–6 complication, recurrence, or
varicothrombosis with combined genotypes. Green shades indicate at least two complications. Brown shades indicate a single complication, while cream indicates no complication.
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Fig. 2 (continued).
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homozygosity at c.677CNT was suggested (Fig. 2d, Suppl. Fig. 5).
Finally, there appeared to be a signiﬁcant association between recur-
rence and varicothrombosis (p = 0.033), as well as between congestive
disease and varicothrombosis (p = 0.015) irrespective of genotype.
The relationships and genotypes are summarized in Table 3.
4. Discussion
In this study, we differentially attributed varying morphological
presentations and clinical phenotypes of primary varicose vein disorder
to the genotypes at MTHFR polymorphisms c.677CNT and c.1298ANC.
The axial trunk type morphology was almost exclusively associatedwith heterozygosity or homozygosity at c.677CNT, the perforator type
morphology with heterozygosity or homozygosity at c.1298ANC and
in particular double heterozygosity CTAC at c.677CNT and
c.1298ANC with the combined trunk and perforator phenotypes.
The association of mutant genotype at c.1298ANC (Table 2, Fig. 2c)
with congestive disease was statistically highly signiﬁcant. The visual
association of junctional and perforator type recurrence with mutant
genotypes at c.677CNT and c.1298ANC (Fig. 2d, Suppl. Fig. 3, Suppl.
Table 8), respectively (although not statistically signiﬁcant due to
small sample size and combined consideration), further indicates a dis-
tinct genetic nature in recurrent disease. Finally, a comparable distribu-
tion of trunk varices among wildtype, heterozygous or homozygous
genotypes at c.677CNT (Fig. 2d, Suppl. Fig. 5) suggests a stochastic origin
Table 3
Associations of morphological phenotypes and clinical courses withMTHFR c.677CNT and
c.1298ANC combined genotypes.
1298
677
AA AC CC
CC unclear, mostlikely trunk type
perforator type,
increasing risk
of CEAP C3–6
perforator type,
highest risk of
CEAP C3–6, 
CT trunk type
trunk and
perforator type,
increasing risk
of CEAP C3–6
TT trunk type
163C. Wilmanns et al. / EBioMedicine 2 (2015) 158–164of varicothrombosis in patients with trunk type morphology. The origin
of complicated diseasemay thus be further linked to speciﬁcmutant ge-
notypes atMTHFR (Suppl. Fig. 4; accordingly, however, not statistically
signiﬁcant too at combined consideration), but the detection of further
statistically signiﬁcant differences was precluded due to small sample
size and constraints of the statistical methods used.
The assessment of primary varicose veins is routinely performed by
clinical and duplex examination. Perforator incompetence contributes
to retrograde axial incompetence of the greater or smaller saphenous
veins. The more distal incompetent perforators are localized, the easier
it is to discriminate between trunk, perforator, or combined trunk and
perforator type morphology by duplex examination. This explains the
associations between unclear phenotypes and homozygous wildtype
(CC) genotype at c.677CNT as well as perforator phenotype and mutant
c.1298ANC.
The c.677CNT polymorphism leads to an alanine to valine substitution
at codon position 222 (p.Ala222Val) in the presumed catalytic domain of
the MTHFR protein, whereas the c.1298ANC polymorphism results in a
glutamate to alanine in substitution at codon position 429 (p.Glu429Ala)
within the predicted C-terminal regulatory domain of theMTHFR protein
(Van der Put et al., 1998). Associations with theMTHFR polymorphisms
c.677CNT and c.1298ANC have been reported in arterial occlusive disease
(Ilhan et al., 2008), neural tube defects (Van der Put et al., 1998) and late
occurrence of colon cancer (Fernández-Peralta et al., 2010). Themolecular
origins of these associations are unknown and possible associations with
complicated phenotypes have not been described. The reduced enzyme
activity of theMTHFR polymorphisms c.677CNT and c.1298ANC has been
further linked to decreased DNAmethylation (Castro et al., 2004) and hy-
perhomocysteinemia (Samet al., 2003). DecreasedDNAmethylationmay
involve aberrant expression of structural and matrix proteins or reduced
DNA integrity resulting in premature aging of venous tissue as essential
step within the pathogenesis of primary varicose veins. The complete ab-
sence of individuals with a double homozygous TTCC genotype, however,
supports a complementary role of both polymorphisms, c.677CNT and
c.1298ANC, ofMTHFR. Yet, we expect other genetic events to be involved
in the pathogenesis of primary varicose veins.Our results provide a fundamental insight into the nature of
primary varicose vein disease. A strong inﬂuence of genotypes at
MTHFR c.677CNT and c.1298A N C on the morphological speciﬁcation
of primary varicose veins and progression towards complicated dis-
ease is suggested. The results provide clues towards the primary or-
igin of congestive (Eklöf et al., 2004; Mozes and Gloviczki, 2004;
Whiteley and O'Donnell, 2014) as well as the natural understanding
of recurrent (Perrin et al., 2000; Stonebridge et al., 1995) disease and
favor an early decision towards surgical therapy in case of homozygous
or double heterozygous MTHFR c.677CNT and c.1298ANC mutant
genotypes. The described connections indicate possible genetic and epi-
genetic pathways involved andmay help to assess the natural impact of
bothMTHFR polymorphisms.
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